SNCA and Parkinson disease: Pathologically, PD is defined by the progressive dopaminergic neuronal loss in the substantia nigra pars compacta (SNpc) and the formation of intraneuronal Lewy bodies, cytoplasmic inclusions primarily comprising α-synuclein (α-syn) fibrils (5, 6).